NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.210
+0.120 (11.01%)
Dec 5, 2025, 4:00 PM EST - Market closed
NovaBay Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 3.24 | -7.22 | -9.64 | -10.61 | -5.82 | -11.04 | Upgrade
|
| Depreciation & Amortization | 0.23 | 0.38 | 0.36 | 0.48 | 0.12 | 0.05 | Upgrade
|
| Other Amortization | 0.09 | 0.87 | 1.69 | - | - | 0.14 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.87 | 0.87 | - | - | - | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.68 | - | - | 6.8 | - | - | Upgrade
|
| Stock-Based Compensation | 0.02 | 0.15 | 0.29 | 0.22 | 1.17 | 0.75 | Upgrade
|
| Other Operating Activities | -10.23 | 0.35 | -0.02 | -4.09 | -4.62 | 5.16 | Upgrade
|
| Change in Accounts Receivable | -0.32 | 0.29 | 0.85 | -0.31 | 0.45 | -0.32 | Upgrade
|
| Change in Inventory | -0.27 | -0.27 | 0.16 | -0.22 | -0.24 | -0.12 | Upgrade
|
| Change in Accounts Payable | 0.51 | -0.2 | -1.13 | 0.67 | -0.16 | 0.32 | Upgrade
|
| Change in Other Net Operating Assets | -0.34 | -0.42 | -0.31 | 0.39 | -0.08 | 0.32 | Upgrade
|
| Operating Cash Flow | 2.96 | -5.39 | -4.63 | -6.65 | -9.19 | -4.72 | Upgrade
|
| Capital Expenditures | -0 | -0.01 | -0.02 | -0.11 | -0.05 | -0.03 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -11.99 | - | Upgrade
|
| Divestitures | 1.07 | 1.07 | - | - | - | - | Upgrade
|
| Investing Cash Flow | 1.07 | 1.06 | -0.02 | -0.11 | -12.05 | -0.03 | Upgrade
|
| Short-Term Debt Issued | - | 0.5 | 3 | - | 0.11 | - | Upgrade
|
| Total Debt Issued | 0.5 | 0.5 | 3 | - | 0.11 | - | Upgrade
|
| Short-Term Debt Repaid | - | -1.99 | -1.47 | -0.11 | - | -2.56 | Upgrade
|
| Total Debt Repaid | -1.03 | -1.99 | -1.47 | -0.11 | - | -2.56 | Upgrade
|
| Net Debt Issued (Repaid) | -0.53 | -1.49 | 1.53 | -0.11 | 0.11 | -2.56 | Upgrade
|
| Issuance of Common Stock | 0.85 | 3.11 | 0.57 | 1.7 | 1.78 | 12.33 | Upgrade
|
| Other Financing Activities | -1.99 | -0.12 | -0.18 | - | - | - | Upgrade
|
| Financing Cash Flow | -2.7 | 1.5 | 1.91 | 4.63 | 16.79 | 9.76 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0.13 | 0.13 | 0.3 | - | - | - | Upgrade
|
| Net Cash Flow | 1.45 | -2.7 | -2.45 | -2.13 | -4.45 | 5.02 | Upgrade
|
| Free Cash Flow | 2.95 | -5.4 | -4.65 | -6.77 | -9.24 | -4.75 | Upgrade
|
| Free Cash Flow Margin | 28.66% | -55.16% | -44.51% | -46.97% | -90.59% | -47.78% | Upgrade
|
| Free Cash Flow Per Share | 0.42 | -1.59 | -38.77 | -147.09 | -259.45 | -165.79 | Upgrade
|
| Cash Interest Paid | 0.03 | 0.15 | 0.17 | 0.02 | - | 0.05 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.02 | 0.02 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -2.64 | -0.44 | -0.6 | -3.85 | -6.96 | -2.67 | Upgrade
|
| Unlevered Free Cash Flow | -2.7 | -0.75 | -1.23 | -3.85 | -6.96 | -2.81 | Upgrade
|
| Change in Working Capital | -0.42 | -0.6 | -0.43 | 0.53 | -0.04 | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.